RKIP regulates bone marrow macrophage differentiation to mediate osteoclastogenesis and H-type vessel formation
Zeyu Zheng,
Siyue Tao,
Jiayan Jin,
Yansong Li,
Liya Dai,
Zhaobo Huang,
Yihao Zhao,
Bao Huang,
Saijilafu,
Wenlong Lin,
Xiaojian Wang,
Mengrui Wu (),
Jian Chen () and
Fengdong Zhao ()
Additional contact information
Zeyu Zheng: Zhejiang University School of Medicine
Siyue Tao: Zhejiang University School of Medicine
Jiayan Jin: Zhejiang University School of Medicine
Yansong Li: Hangzhou Normal University
Liya Dai: Lishui Central Hospital
Zhaobo Huang: Zhejiang University School of Medicine
Yihao Zhao: Zhejiang University School of Medicine
Bao Huang: Zhejiang University School of Medicine
Saijilafu: Hangzhou City University
Wenlong Lin: Zhejiang University School of Medicine
Xiaojian Wang: Zhejiang University School of Medicine
Mengrui Wu: Zhejiang University
Jian Chen: Zhejiang University School of Medicine
Fengdong Zhao: Zhejiang University School of Medicine
Nature Communications, 2025, vol. 16, issue 1, 1-17
Abstract:
Abstract As central cells involved in osteoimmunology, bone niche macrophages possess diverse functions, and their differentiation fate regulates bone homeostasis. Elucidation of the underlying mechanism involved in macrophage differentiation is important for developing new therapeutic targets for osteoporosis. Here, we show that knocking out Raf kinase inhibitor protein (RKIP), either globally or in macrophages, results in dramatically increased bone mass in mice due to synergistic inhibition of bone resorption and promotion of bone formation. Mechanistically, RKIP knockout inhibits differentiation of macrophages into osteoclasts and promotes their differentiation towards pro-angiogenic subclusters, which enhances formation of H-type vessels. RKIP enhances osteoclastogenesis by interacting with ARHGAP to suppress CDC42 inactivation. Intranuclear RKIP suppresses angiogenic genes expression by bridging the association between HIF-1α and VHL to reduce the protein stability of HIF-1α in macrophages. Furthermore, RKIP deletion or inhibitor rescues ovariectomy (OVX)-induced bone loss in vivo. Collectively, this study provides insights into the different roles of extranuclear or intranuclear RKIP in regulating differentiation of bone niche macrophages and could inform potential therapies for bone homeostasis-related diseases.
Date: 2025
References: Add references at CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/s41467-025-62972-8 Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-62972-8
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-025-62972-8
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().